Tuesday, August 1, 2017

Big Trouble for uniQure - Chiesi Drops collaboration - Hemo B

›
uniQure Reacquires Development and Commercialization Rights for its Gene Therapy Candidate in Hemophilia B ~ Company now owns full global...
Monday, July 24, 2017

Xenotransplantation !

›
Sangamo job opening describes areas of interest to include Xenotransplantation. Title: Product Development Sr. Program Manager   Des...
Tuesday, July 11, 2017

uniQure Presents New Clinical Data in Hemophilia B Patients Demonstrating Therapeutic Efficacy of AAV5 Gene Therapy in the Presence of Pre-Existing Neutralizing Antibodies

›
-- Findings Further Support Expanding the Eligibility of AAV5 Gene Therapies to Nearly All Patients with Hemophilia B -- LEXINGTON, Mass...
Friday, July 7, 2017

Biocompare.com Editorial - Gene Editing: Not Just CRISPR

›
http://www.biocompare.com/Editorial-Articles/339420-Gene-Editing-Not-Just-CRISPR/ The impact of gene editing on biomedical research has be...
Thursday, July 6, 2017

Shire Submits IND for Gene Therapy Treatment of Hemophilia A

›
Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A SHP654 aims to d...
Friday, June 23, 2017

Article - Fixing Crispr

›
http://www.genengnews.com/gen-exclusives/fixing-crispr/77900928 Elegant in its simplicity and easily accessible to most laboratories, CRI...
Thursday, June 22, 2017

Hemophilia B Article - Genetic Literacy Project

›
https://geneticliteracyproject.org/2017/06/22/blood-disease-plagued-europes-royal-families-might-treatable-using-gene-editing/ It was once ...